The Washington Post
Mediocre Vaccine Rollout May Delay Recovery
A recent BCG report indicates that significant work remains to get through the pandemic. BCG’s CEO, Rich Lesser, tells The Washington Post that Americans, in particular, should expect another full year of “suspended new normal.” The report indicates that the most likely scenario for the US is a “good-but-not-great rollout” of a vaccine, which would delay defeating the pandemic until the first quarter of 2022. An even longer setback is possible due to less effective trials and delayed authorization and distribution of the vaccines. “I expect a year from now there will be a lot of reasons to be optimistic, and we'll go into next winter feeling very different than we’re going into this winter,” says Lesser.